Association between cognitive impairment and chronic kidney disease in Mexican Americans

Journal of the American Geriatrics Society

Volumn 63, Issue 10, 2015, Pages 2023-2028

  Szerlip, Harold M ^a,b   Edwards, Melissa L ^a   Williams, Benjamin J ^c   Johnson, Leigh A ^a   Vintimilla, Raul M ^a   O'Bryant, Sid E ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

chronic kidney disease; cognitive impairment; Mexican Americans; neuropsychological testing; proteomics

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN; INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL FUNCTION; MENTAL PERFORMANCE; MEXICAN AMERICAN; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PROTEOMICS; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; VISUOSPATIAL SKILL; BLOOD; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; SEX DIFFERENCE; UNITED STATES;

AGED; AGED, 80 AND OVER; BIOMARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FACTOR VII; FATTY ACID-BINDING PROTEINS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INTERLEUKIN-10; MALE; MEXICAN AMERICANS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES;

EID: 84944607237     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13665     Document Type: Article

References (36)

1. Ennis SR, Rios-Vargas M, Albert NG,. The Hispanic Population: 2010. Washington, DC: Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau, 2011.
2. U.S. Renal Data System. USRDS 2013 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013.
3. Coresh J, Astor BC, Greene T, et al., Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.
4. Coresh J, Selvin E, Stevens LA, et al., Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
5. Bryson CL, Ross HJ, Boyko EJ, et al., Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: Associations with diabetes and level of CKD. Am J Kidney Dis 2006; 48: 720-726.
6. Sinha SK, Shaheen M, Rajavashisth TB, et al., Association of race/ethnicity, inflammation, and albuminuria in patients with diabetes and early chronic kidney disease. Diabetes Care 2014; 37: 1060-1068.
7. Peralta CA, Shlipak MG, Fan D, et al., Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2892-2899.
8. Abbate M, Zoja C, Remuzzi G,. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006; 17: 2974-2984.
9. Persson F, Rossing P, Hovind P, et al., Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study. Scand J Clin Lab Invest 2008; 68: 731-738.
10. Vendemiale G, Romano AD, Dagostino M, et al., Endothelial dysfunction associated with mild cognitive impairment in elderly population. Aging Clin Exp Res 2013; 25: 247-255.
11. Sachs GA, Carter R, Holtz LR, et al., Cognitive impairment: An independent predictor of excess mortality: A cohort study. Ann Intern Med 2011; 155: 300-308.
12. Raphael KL, Wei G, Greene T, et al., Cognitive function and the risk of death in chronic kidney disease. Am J Nephrol 2012; 35: 49-57.
13. Yost KJ, DeWalt DA, Lindquist LA, et al., The association between health literacy and indicators of cognitive impairment in a diverse sample of primary care patients. Patient Educ Couns 2013; 93: 319-326.
14. O'Bryant SE, Humphreys JD, Schiffer RB, et al., Presentation of Mexican Americans to a memory disorder clinic. J Psychopathol Behav Assess 2007; 29: 137-140.
15. O'Bryant SE, Johnson LA, Reisch J, et al., Risk factors for mild cognitive impairment among Mexican Americans. Alzheimers Dement 2013; 9: 622-631.
16. Elias MF, Elias PK, Seliger SL, et al., Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant 2009; 24: 2446-2452.
17. Hailpern SM, Melamed ML, Cohen HW, et al., Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2007; 18: 2205-2213.
18. Kurella M, Chertow GM, Luan J, et al., Cognitive impairment in chronic kidney disease. J Am Geriatr Soc 2004; 52: 1863-1869.
19. Yaffe K, Ackerson L, Tamura MK, et al., Chronic kidney disease and cognitive function in older adults: Findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc 2010; 58: 338-345.
20. Kurella Tamura M, Xie D, Yaffe K, et al., Vascular risk factors and cognitive impairment in chronic kidney disease: The Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol 2011; 6: 248-256.
21. Khatri M, Nickolas T, Moon YP, et al., CKD associates with cognitive decline. J Am Soc Nephrol 2009; 20: 2427-2432.
22. O'Bryant SE, Xiao G, Barber R, et al., A blood-based screening tool for Alzheimer's disease that spans serum and plasma: Findings from TARC and ADNI. PLoS One 2011; 6: e28092.
23. O'Bryant SE, Xiao G, Barber R, et al., A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol 2010; 67: 1077-1081.
24. O'Bryant SE, Xiao G, Barber R, et al., A blood-based algorithm for the detection of Alzheimer's disease. Dement Geriatr Cogn Disord 2011; 32: 55-62.
25. O'Bryant SE, Xiao G, Zhang F, et al., Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues. J Alzheimers Dis 2014; 42: 1325-1335.
26. Lezak MD, Howieson DB, Loring DW,. Neuropsychological Assessment, 4th Ed. Oxford: Oxford University Press, 2004.
27. Royall DR, Cordes JA, Polk M,. CLOX: An executive clock drawing task. J Neurol Neurosurg Psychiatry 1998; 64: 588-594.
28. Strauss E, Sherman EMS, Spreen O,. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd Ed. Oxford: Oxford University Press, 2006.
29. Wechsler D,. Wechsler Memory Scale, 3rd Ed. San Antonio, TX: The Psychological Corporation, 1997.
30. Petersen RC, Negash S,. Mild cognitive impairment: An overview. CNS Spectr 2008; 13: 45-53.
31. Kuhle J, Regeniter A, Leppert D, et al., A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. J Neuroimmunol 2010; 220: 114-119.
32. Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013; 158: 825-830.
33. Bugnicourt JM, Godefroy O, Chillon J-M, et al., Cognitive disorders and dementia in CKD: The neglected kidney-brain axis. J Am Soc Nephrol 2013; 24: 353-363.
34. Fischer MJ, Go AS, Lora CM, et al., CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies. Am J Kidney Dis 2011; 58: 214-227.
35. Lora CM, Daviqlus ML, Kusek JW, et al., Chronic kidney disease in United States Hispanics: A growing public health problem. Ethn Dis 2009; 19: 466-472.
36. Lora CM, Gordon EJ, Sharp LK, et al., Progression of CKD in Hispanics: Potential roles of health literacy, acculturation, and social support. Am J Kidney Dis 2011; 58: 282-290.